AB144070
L-threo-Dihydrosphingosine (Safingol), lyso-sphingolipid PKC inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 301.5 Da, Purity >98%. Cell-permeable, reversible lyso-sphingolipid protein kinase C (PKC) inhibitor (IC50 = 40 μM). Anticancer agent. Potentiates effect of Doxorubicin (DOX) (ab120629) in tumor-bearing animals and cytotoxicity ofMitomycin C (ab120797) in cancer cells. Active in vivo and in vitro.
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Annals of translational medicine 9:1470 PubMed34734022
2021
Cold-inducible RNA-binding protein migrates from the nucleus to the cytoplasm under cold stress in normal human bronchial epithelial cells via TRPM8-mediated mechanism.
Applications
Unspecified application
Species
Unspecified reactive species
Liang-Ping Mao,Yan Jiao,Jian-Hua Xiang,Xin-Wei Luo,Qian He,Dan-Hua Ran,Qing Xu,Chun-Hui Lang,Ling-Xiu Chen
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com